Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Denosumab May Help Prevent Bone Loss Bortezomib for Initial Therapy in Multiple Myeloma Past Highlights



Results: 1 -2 of 2 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Androgen Suppression Alone or Combined With Zoledronate, Docetaxel, Prednisolone, and/or Celecoxib in Treating Patients With Locally Advanced or Metastatic Prostate Cancer				Phase III, Phase II				MRC-STAMPEDE EU-205102, MRC-PR08, ISRCTN78818544, EUDRACT-2004-000193-31, NCT00268476
	Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer				Phase III				EFC6546 AVE0005, NCT00519285

| | | | | | | |

A Service of the National Cancer Institute